320
References
- Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor
RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med.
1992;327:1912–8. - Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn
KH. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106:1974–9. - Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, Dell'Oro R,
Mancia G. Early sympathetic activation in the initial clinical stages of chronic renal failure.
Hypertension. 2011;57:846–51. - Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection
of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens.
2002;15:717–24. - Johns EJ, Abdulla MH. Renal nerves in blood pressure regulation. Curr Opin Nephrol
Hypertens. 2013;22:504–10. - Penne EL, Neumann J, Klein IH, Oey PL, Bots ML, Blankestijn PJ. Sympathetic hyperactivity
and clinical outcome in chronic kidney disease patients during standard treatment. J Nephrol.
2009;22:208–15. - Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G,
Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS. Plasma norepi-
nephrine predicts survival and incident cardiovascular events in patients with end-stage renal
disease. Circulation. 2002;105:1354–9. - Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension; results in 1,266
cases. J Am Med Assoc. 1953;152:1501–4. - Sakakura K, Ladich E, Cheng Q, Otsuka F, Yahagi K, Fowler DR, Kolodgie FD, Virmani R,
Joner M. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll
Cardiol. 2014;640:635–43. - Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A,
Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation
for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet.
2009;373:1275–81. - Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic
denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a
randomised controlled trial. Symplicity HTN-2 investigators. Lancet. 2010;376:1903–9. - Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu
M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR. Bakris GL;
SYMPLICITY HTN-3 investigators. A controlled trial of renal denervation for resistant hyper-
tension. N Engl J Med. 2014;370:1393–401. - Rosa J, Widimsky P, Touek P, Petrak O, Curila K, Waldauf P, Bedna F, Zelinka T, Holaj R,
Strauch B, Somloova Z, Taborsky M, Vaclavik J, Kocianova E, Branny M, Nykl I, Jiravsky
O, Widimsky J. Randomized comparison of renal denervation versus intensified pharmaco-
therapy including spironolactone in true-resistant hypertension: six-month results from the
Prague-15 study. Hypertension. 2015;65(2):407–13. - Desch S, Okon T, Heinemann D, Kulle K, Röhnert K, Sonnabend M, Petzold M, Müller U,
Schuler G, Eitel I, Thiele H, Lurz P. Randomized sham-controlled trial of renal sympathetic
denervation in mild resistant hypertension. Hypertension. 2015;65:1202–8. - Bunte MC, Infante de Oliveira E, Shishehbor MH. Endovascular treatment of resistant and
uncontrolled hypertension: therapies on the horizon. JACC Cardiovasc Interv. 2013;6:1–9. - Hering D, Mahfoud F, Walton AS, Krum H, Lambert GW, Lambert EA, Sobotka PA, Böhm M,
Cremers B, Esler MD, Schlaich MP. Renal denervation in moderate to severe CKD. J Am Soc
Nephrol. 2012;23:1250–7.
M. Adamczak et al.